A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02) | MicrobiomeTrials← Back to trialsNCT07221253
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-12-04Est. Completion: 2029-07-31
Enrollment target: 1,100 participants Locations- Research Site, Birmingham, Alabama, United States
- Research Site, Phoenix, Arizona, United States
- Research Site, Tucson, Arizona, United States
- Research Site, Duarte, California, United States
- Research Site, Orange, California, United States
- Research Site, Palo Alto, California, United States
- Research Site, Santa Monica, California, United States
- Research Site, Aurora, Colorado, United States
- Research Site, Hartford, Connecticut, United States
- Research Site, New Haven, Connecticut, United States
- Research Site, Washington D.C., District of Columbia, United States
- Research Site, Washington D.C., District of Columbia, United States
- Research Site, Gainesville, Florida, United States
- Research Site, Jacksonville, Florida, United States
- Research Site, Marietta, Georgia, United States
- Research Site, Chicago, Illinois, United States
- Research Site, Chicago, Illinois, United States
- Research Site, Indianapolis, Indiana, United States
Other microbiome trials you might be interested in
Bile Duct CarcinomaCholangiocarcinoma
This study is a prospective, multicenter, open-label, umbrella phase II clinical trial. Based on different multigene exp…
Hangzhou, ChinaEst. completion Aug 31, 2028
Cancer Harboring BRAF AlterationsHGGLGGSolid Tumors
The objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with BRAF a…
Beverly Hills, United StatesEst. completion Dec 31, 2027
Research Site, Louisville, Kentucky, United StatesResearch Site, Baltimore, Maryland, United StatesResearch Site, Ann Arbor, Michigan, United StatesResearch Site, Detroit, Michigan, United StatesResearch Site, Rochester, Minnesota, United StatesResearch Site, Omaha, Nebraska, United StatesResearch Site, Santa Fe, New Mexico, United StatesResearch Site, New York, New York, United StatesResearch Site, New York, New York, United StatesResearch Site, New York, New York, United StatesResearch Site, Portland, Oregon, United StatesResearch Site, Lancaster, Pennsylvania, United StatesResearch Site, Philadelphia, Pennsylvania, United StatesResearch Site, Pittsburgh, Pennsylvania, United StatesResearch Site, Providence, Rhode Island, United StatesResearch Site, Pierre, South Dakota, United StatesResearch Site, Sioux Falls, South Dakota, United StatesResearch Site, Houston, Texas, United StatesResearch Site, Clayton, AustraliaResearch Site, Darlinghurst, AustraliaResearch Site, Gosford, AustraliaResearch Site, Murdoch, AustraliaResearch Site, Anderlecht, BelgiumResearch Site, Edegem, BelgiumResearch Site, Leuven, BelgiumResearch Site, Liège, BelgiumResearch Site, Roeselare, BelgiumResearch Site, Barretos, BrazilResearch Site, Natal, BrazilResearch Site, Porto Alegre, BrazilResearch Site, Ribeirão Preto, BrazilResearch Site, São Paulo, BrazilResearch Site, Vitória, BrazilResearch Site, Calgary, Alberta, CanadaResearch Site, Vancouver, British Columbia, CanadaResearch Site, Halifax, Nova Scotia, CanadaResearch Site, Barrie, Ontario, CanadaResearch Site, Toronto, Ontario, CanadaResearch Site, Toronto, Ontario, CanadaResearch Site, Montreal, Quebec, CanadaResearch Site, Québec, Quebec, CanadaResearch Site, Beijing, ChinaResearch Site, Beijing, ChinaResearch Site, Changchun, ChinaResearch Site, Changde, ChinaResearch Site, Changsha, ChinaResearch Site, Changsha, ChinaResearch Site, Chengdu, ChinaResearch Site, Fuzhou, ChinaResearch Site, Guangzhou, ChinaResearch Site, Hangzhou, ChinaResearch Site, Hefei, ChinaResearch Site, Kunming, ChinaResearch Site, Lishui, ChinaResearch Site, Luoyang, ChinaResearch Site, Nanchang, ChinaResearch Site, Nanning, ChinaResearch Site, Shandong, ChinaResearch Site, Shanghai, ChinaResearch Site, Shenyang, ChinaResearch Site, Weifang, ChinaResearch Site, Wuhan, ChinaResearch Site, Xi'an, ChinaResearch Site, Clichy, FranceResearch Site, Grenoble, FranceResearch Site, Marseille, FranceResearch Site, Vandœuvre-lès-Nancy, FranceResearch Site, Aachen, GermanyResearch Site, Berlin, GermanyResearch Site, Berlin, GermanyResearch Site, Bonn, GermanyResearch Site, Düsseldorf, GermanyResearch Site, Essen, GermanyResearch Site, Frankfurt, GermanyResearch Site, Freiburg im Breisgau, GermanyResearch Site, Hamburg, GermanyResearch Site, Hamburg, GermanyResearch Site, Heidelberg, GermanyResearch Site, Heilbronn, GermanyResearch Site, Karlsruhe, GermanyResearch Site, Magdeburg, GermanyResearch Site, München, GermanyResearch Site, München, GermanyResearch Site, Ulm, GermanyResearch Site, Delhi, IndiaResearch Site, Hyderabad, IndiaResearch Site, Kolhāpur, IndiaResearch Site, Kolkata, IndiaResearch Site, Mumbai, IndiaResearch Site, Nashik, IndiaResearch Site, Surat, IndiaResearch Site, Castellana Grotte, ItalyResearch Site, Milan, ItalyResearch Site, Pisa, ItalyResearch Site, Rome, ItalyResearch Site, Rozzano, ItalyResearch Site, Chiba, JapanResearch Site, Kashiwa, JapanResearch Site, Kawasaki-shi, JapanResearch Site, Kōtoku, JapanResearch Site, Matsuyama, JapanResearch Site, Nagoya, JapanResearch Site, Nagoya, JapanResearch Site, Osaka, JapanResearch Site, Suita-shi, JapanResearch Site, Takatsuki-shi, JapanResearch Site, Ube, JapanResearch Site, Yokohama, JapanResearch Site, Amsterdam, NetherlandsResearch Site, Groningen, NetherlandsResearch Site, Maastricht, NetherlandsResearch Site, Utrecht, NetherlandsResearch Site, Koszalin, PolandResearch Site, Krakow, PolandResearch Site, Lodz, PolandResearch Site, Olsztyn, PolandResearch Site, Warsaw, PolandResearch Site, Busan, South KoreaResearch Site, Daegu, South KoreaResearch Site, Seongnam-si, South KoreaResearch Site, Seongnam-si, South KoreaResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Site, Barcelona, SpainResearch Site, L'Hospitalet de Llobregat, SpainResearch Site, Madrid, SpainResearch Site, Madrid, SpainResearch Site, Santander, SpainResearch Site, Kaohsiung City, TaiwanResearch Site, Kaohsiung City, TaiwanResearch Site, Taichung, TaiwanResearch Site, Taichung, TaiwanResearch Site, Tainan, TaiwanResearch Site, Taipei, TaiwanResearch Site, Taipei, TaiwanResearch Site, Taoyuan, TaiwanResearch Site, Bangkok, ThailandResearch Site, Chiang Mai, ThailandResearch Site, Hat Yai, ThailandResearch Site, Khon Kaen, ThailandResearch Site, Muang, ThailandResearch Site, Ongkharak, ThailandResearch Site, Ankara, Turkey (Türkiye)Research Site, Erzurum, Turkey (Türkiye)Research Site, Istanbul, Turkey (Türkiye)Research Site, Konya, Turkey (Türkiye)Research Site, Seyhan, Turkey (Türkiye)Research Site, Birmingham, United KingdomResearch Site, Glasgow, United KingdomResearch Site, Greater London, United KingdomResearch Site, Leeds, United KingdomResearch Site, London, United KingdomResearch Site, Manchester, United KingdomAdvanced Biliary Tract Cancers
This is a prospective, single-arm, Phase II study evaluating sacituzumab tirumotecan combined with envafolimab in patien…
Tianjin, ChinaEst. completion Dec 2027